S Zhang, MK Anser, MYP Peng, C Chen - Resources Policy, 2023 - Elsevier
After the COVID-19 outbreak, this study examines the influence of modifications in China's Sustainable Growth Goals (SDGs) and economic development goals on Chinese …
J Yang, Y Gong, C Zhang, J Sun, G Wong, W Shi, W Liu… - The Innovation, 2022 - cell.com
Since the 20 th century, humans have lived through five pandemics caused by influenza A viruses (IAVs)(H1N1/1918, H2N2/1957, H3N2/1968, and H1N1/2009) and the coronavirus …
G Kenny, S O'Reilly, N Wrigley Kelly, R Negi… - Nature …, 2023 - nature.com
SARS-CoV-2 neutralising antibodies provide protection against COVID-19. Evidence from early vaccine trials suggested binding antibody thresholds could serve as surrogate markers …
Z Wang, TT Le - Economic Analysis and Policy, 2022 - Elsevier
This study is based on the system resilience framework, which outlines the aspects of community behavior, employees, the environment, history, and corporate social …
R MacCann, AAG Leon, G Gonzalez, MJ Carr… - Frontiers in …, 2023 - frontiersin.org
Background Dysregulated immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are thought to underlie the progression of coronavirus …
R Chicea, AD Neagu, ED Chicea… - Journal of Clinical …, 2023 - mdpi.com
Background: As the COVID-19 pandemic evolved, concerns grew about its impact on pregnant women. This study aimed to determine how SARS-CoV-2 affects pregnancy, birth …
G Kenny, R Negi, S O'Reilly, A Garcia-Leon… - Journal of …, 2022 - Elsevier
Measurement of quantitative antibody responses are increasingly important in evaluating the immune response to infection and vaccination. In this study we describe the validation of …
C Umeh, L Tuscher, S Ranchithan, K Watanabe… - Cureus, 2022 - cureus.com
Introduction Coronavirus disease 2019 (COVID-19) is a multisystemic disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and can lead to a broad …
G Kenny, K McCann, C O'Brien, C O'Broin… - BMC Infectious …, 2023 - Springer
Background Defining patterns of symptoms in long COVID is necessary to advance therapies for this heterogeneous condition. Here we aimed to describe clusters of symptoms …